Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress ReleasesSoleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1M ago
Soleno Therapeutics Announces Board Reshuffle and New Appointments
Premium
Company Announcements
Soleno Therapeutics Announces Board Reshuffle and New Appointments
1M ago
Soleno Therapeutics Announces Updates to its Board of Directors
Premium
Press Releases
Soleno Therapeutics Announces Updates to its Board of Directors
1M ago
Soleno Therapeutics Announces Submission of New Drug Application to the U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets for the Treatment of Prader-Willi Syndrome
PremiumPress ReleasesSoleno Therapeutics Announces Submission of New Drug Application to the U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets for the Treatment of Prader-Willi Syndrome
3M ago
Soleno Therapeutics submits NDA for DCCR extended-release tablets
Premium
The Fly
Soleno Therapeutics submits NDA for DCCR extended-release tablets
3M ago
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Premium
Press Releases
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3M ago
Soleno Therapeutics launches initiative in honor of PWS Awareness Day
PremiumThe FlySoleno Therapeutics launches initiative in honor of PWS Awareness Day
4M ago
Soleno Therapeutics Stands with the Prader-Willi Syndrome Community
Premium
Press Releases
Soleno Therapeutics Stands with the Prader-Willi Syndrome Community
4M ago
Soleno Therapeutics management to meet with Piper Sandler
Premium
The Fly
Soleno Therapeutics management to meet with Piper Sandler
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100